24 August 2026
Cancer sugar shield research from UCT reveals how tumours evade immunity and could support new vaccines, biomarkers and precision therapies.
20 August 2026
A Moderna-Merck melanoma vaccine reduces recurrence and spread in a late-stage trial, boosting hopes for mRNA cancer treatments.